Fingerprint
Dive into the research topics of 'Efficacy and safety of low-dose otelixizumab anti-CD3 monoclonal antibody in preserving C-peptide secretion in adolescent type 1 diabetes: DEFEND-2, a randomized, placebo-controlled, double-blind, multi-centre study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically